Light has been used in medicine for centuries. Early civilizations used sunlight for therapeutic purposes, while modern medical technology now uses more specific wavelengths for targeted applications.
Today, ultraviolet, visible and infrared light can each interact with human tissue in different ways. These interactions can support medical applications such as phototherapy, diagnostics, wound care research, biosensing and sterilization.
For medical device teams, wavelength selection is not just a scientific detail. It affects tissue depth, safety, thermal behavior, optical design and how light should be delivered inside a device.
Understanding light therapy for medical devices starts with understanding how different wavelengths interact with tissue.
Different light wavelengths penetrate skin and tissue at different depths. Some wavelengths remain closer to the surface, while others can reach deeper tissue layers.
This matters because medical applications often depend on where the light needs to act. A surface-level skin treatment may need a different wavelength than a deep tissue application or diagnostic sensor.
Wavelength behavior can be affected by several factors:
Medical device designers must evaluate these factors carefully. The goal is not simply to choose a bright light source. The goal is to deliver the right wavelength to the right area with appropriate control.
Ultraviolet light ranges from about 100 to 400 nanometers. It is often discussed in three major categories: UV-A, UV-B and UV-C.
Each category interacts with tissue differently. Some UV ranges are used in controlled medical settings, while others are more commonly associated with sterilization or safety risk.
UV-A light ranges from about 320 to 400 nanometers. It can penetrate into the dermis and has been used in controlled phototherapy applications for certain skin conditions.
Because UV-A can penetrate deeper than some other UV ranges, exposure must be carefully managed. Prolonged or improper exposure may contribute to skin aging and higher long-term skin risk.
UV-B light ranges from about 290 to 320 nanometers. It mainly interacts with the epidermis and has been used in controlled dermatology applications.
UV-B exposure must also be carefully managed. Too much exposure can damage skin, which is why dose, duration and clinical oversight matter.
UV-C light ranges from about 100 to 290 nanometers. It is best known for germicidal and sterilization applications.
Because UV-C can damage biological material, safety controls are especially important. Medical and sterilization systems using UV-C must be designed to manage exposure risk.
Visible light ranges from about 400 to 700 nanometers. This spectrum is perceived as different colors, and each color range can interact with tissue in a different way.
Visible wavelengths are used in several medical and wellness applications. These may include neonatal jaundice treatment, dermatology, light-based diagnostics and phototherapy research.
Blue light generally falls around 440 to 500 nanometers. It can reach upper skin layers and is often associated with neonatal jaundice treatment, acne-related applications and antibacterial effects.
Because blue light can also affect the eyes, exposure level and duration should be controlled in medical device design.
Green light generally falls around 500 to 570 nanometers. It can reach upper dermal layers and may be used in applications related to pigmentation and optical response.
Green light may also be useful in certain diagnostic or imaging contexts depending on the device and target tissue.
Yellow light generally falls around 570 to 590 nanometers. It can interact with dermal tissue and is often discussed in relation to skin appearance, collagen-related research and calming visual effects.
For medical device design, yellow light must still be evaluated based on the intended use, output level and safety requirements.
Red light generally falls around 620 to 750 nanometers. It can penetrate deeper than shorter visible wavelengths and is commonly discussed in wound healing, inflammation and photobiomodulation research.
Red light is one of the most important wavelength ranges for teams exploring therapeutic light delivery. For a deeper explanation of PBM device design, see Lumitex’s guide to photobiomodulation therapy devices.
Infrared light begins around 700 nanometers and extends toward 1 millimeter. It is commonly divided into near-infrared, mid-infrared and far-infrared light.
Infrared wavelengths are often used when deeper penetration or thermal interaction is important. However, longer wavelengths can also create heat-related concerns if not properly controlled.
Near-infrared light generally ranges from about 700 to 1,400 nanometers. It can reach deeper tissue structures than many visible wavelengths.
Near-infrared light is often discussed in pain management, deep tissue repair research and photobiomodulation applications. Device teams must consider tissue depth, dose and heat behavior when using this range.
Mid-infrared light generally ranges from about 1,400 to 3,000 nanometers. It is often associated with thermal effects.
This range may be used where controlled heating is part of the intended application. Because heat can affect tissue safety, thermal management becomes a key design requirement.
Far-infrared light generally ranges from about 3,000 nanometers to 1 millimeter. It is often associated with surface-level heating and circulation-related applications.
Medical or wellness systems using far-infrared light must control heat exposure and avoid excessive thermal buildup.
Medical applications use different wavelengths based on the target tissue, treatment goal, diagnostic need and safety profile. No single wavelength is right for every use case.
Common light-based medical applications include:
Each application requires a different design approach. Wavelength, intensity, beam shape, exposure time and delivery method must all match the intended use.
Optical biosensors use light to detect and analyze biological molecules or chemical substances. These sensors measure changes in light properties such as absorption, fluorescence, luminescence or reflectance.
In healthcare, optical biosensors can support sensitive, real-time and noninvasive monitoring. They may be used in diagnostic systems, wearable devices or research tools.
Wavelength selection is important because each biological target may respond differently to light. Signal quality, color temperature, excitation wavelength and sensor placement can all affect performance.
For device teams, optical biosensors require careful coordination between light source, detector, optics and biological target.
Photobiomodulation, often called PBM, uses specific wavelengths of light to interact with cells and tissue. Red and near-infrared wavelengths are commonly discussed in PBM research.
In wound care research, PBM is often studied for its potential role in supporting cellular activity, inflammation response and tissue repair. However, results can depend on wavelength, dose, exposure time and treatment protocol.
The design challenge is delivering enough usable light to the target tissue without creating unwanted heat or uneven exposure.
PBM is also being studied in neurological applications. Some research explores red or near-infrared light in relation to brain function, cellular activity and inflammatory response.
These applications are complex because the target tissue is deeper and more difficult to reach. Wavelength selection, optical power, delivery method and safety controls become especially important.
Current research continues to evaluate how PBM may apply to neurological conditions. Medical device teams should treat this as an area that requires careful clinical validation and cautious design.
Bioluminescence is the natural process where living organisms emit light through chemical reactions. In medical research, bioluminescence can help scientists observe biological activity in controlled settings.
Most bioluminescence involves luciferin and luciferase. This reaction can produce light with limited heat generation.
In research, bioluminescent markers can help track disease progression, treatment response or cellular behavior. This can support preclinical imaging and drug discovery.
Bioluminescence is not the same as external light therapy, but it shows how light-based methods can support modern medicine beyond illumination alone.
Light-based medical applications must be designed with safety in mind. The same wavelength that supports one use case may create risk if exposure is too high, too long or poorly controlled.
Risk depends on several factors:
Medical device teams must account for these risks through design controls, labeling, testing and appropriate safety guidance.
UV radiation can cause acute skin irritation and longer-term skin damage if exposure is not controlled. Chronic exposure may also increase the risk of photo-aging and certain skin cancers.
The eyes are also sensitive to UV radiation. Excessive exposure may contribute to eye irritation, photokeratitis or other eye-related concerns.
UV-based medical or sterilization systems must include careful exposure controls.
Visible light is often viewed as safer than UV, but it can still create risk when exposure is intense or prolonged. Blue light is one example because excessive exposure may contribute to eye strain or retinal concerns.
Visible light systems should be designed around output limits, user environment and intended exposure duration.
Infrared radiation can create heat. If heat is not controlled, it may lead to skin burns, heat rash or tissue discomfort.
Infrared systems must be designed with thermal management in mind. This includes controlling power, exposure time, device distance and heat dissipation.
Wavelength selection affects more than the medical application. It also affects the full device design.
A medical light device must account for:
This is why light-based medical device design requires close coordination between optical engineering, device design and clinical use requirements.
For therapy-focused applications, Lumitex’s guide to phototherapy lighting explains how solid-state light sources, optics and device format affect medical light delivery.
Lumitex helps medical device teams engineer light into products where wavelength, light delivery and device integration matter.
For light-based medical applications, teams often need support with optical output, uniformity, wavelength delivery, form factor, thermal behavior and manufacturability.
Lumitex works with teams developing surgical, therapeutic and diagnostic lighting systems where light must be controlled and delivered with purpose. If your team is exploring a light-based medical device, talk to an expert about your application.
Light wavelengths play an important role in modern medical applications. UV, visible and infrared light each interact with tissue differently, which makes wavelength selection central to both performance and safety.
These wavelengths may support applications such as phototherapy, biosensing, PBM research, sterilization, imaging and diagnostic monitoring. However, each use case requires careful control of light output, exposure time, delivery method and thermal behavior.
For medical device teams, success depends on matching the right wavelength to the right target and designing the device around real clinical use conditions.
As light-based medicine continues to develop, optical engineering will remain essential for safer, more precise and more useful medical technologies.
Light wavelengths in medical applications refer to specific ranges of light used for therapy, diagnostics, imaging, sterilization or research. Different wavelengths interact with tissue in different ways.
Medical devices use different light wavelengths because each range penetrates tissue differently. Wavelength affects depth, absorption, thermal behavior and biological response.
UV light has shorter wavelengths and is often used in dermatology or sterilization. Visible light includes blue, green, yellow and red light. Infrared light has longer wavelengths and is often associated with deeper penetration or thermal effects.
Light therapy may use ultraviolet, visible or infrared wavelengths depending on the intended application. Red and near-infrared wavelengths are commonly discussed in photobiomodulation research.
Wavelength selection affects tissue interaction, safety, heat, light delivery and device performance. Choosing the wrong wavelength can reduce effectiveness or increase risk.
Yes. UV, visible and infrared light can create safety risks if exposure is too high, too long or poorly controlled. Medical light devices must manage dose, heat, eye exposure and user safety.
Lumitex helps medical device teams engineer controlled light delivery for surgical, therapeutic and diagnostic applications. This can include wavelength delivery, optical design, uniformity, thermal behavior and device integration.
Resources: